Long-Term Outcomes for Patients with Multiple Endocrine Neoplasia Type 1 and Duodenopancreatic Neuroendocrine Neoplasms.
Ann Surg Oncol
; 29(12): 7808-7817, 2022 Nov.
Article
in En
| MEDLINE
| ID: mdl-35963905
Full text:
1
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Neuroendocrine Tumors
/
Multiple Endocrine Neoplasia Type 1
/
Liver Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Year:
2022
Type:
Article